{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:19:41Z","timestamp":1768547981861,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.amjcard.2015.12.003","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T01:09:17Z","timestamp":1450228157000},"page":"703-708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Relation of Activated Clotting Times During Percutaneous Coronary Intervention to Outcomes"],"prefix":"10.1016","volume":"117","author":[{"given":"Naveen","family":"Rajpurohit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan J.","family":"Lennon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charanjit S.","family":"Rihal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula J.","family":"Santrach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie J.","family":"Donato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brad S.","family":"Karon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freddy","family":"Del-Carpio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahir","family":"Tak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arashk","family":"Motiei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato D.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahyar Michael","family":"Gharacholou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2015.12.003_bib1","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1161\/CIR.0b013e31823ba622","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.12.003_bib2","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1161\/CIR.0b013e3182742c84","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O'Gara","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.12.003_bib3","doi-asserted-by":"crossref","first-page":"50P","DOI":"10.1016\/S0002-9149(98)00760-7","article-title":"Relation between abrupt vessel closure and the anticoagulant response to heparin or bivalirudin during coronary angioplasty","volume":"82","author":"Bittl","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2015.12.003_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ccd.20355","article-title":"Reproducibility and variability of activated clotting time measurements in the cardiac catheterization laboratory","volume":"65","author":"Doherty","year":"2005","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2015.12.003_bib5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/01.CIR.103.7.961","article-title":"Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials","volume":"103","author":"Chew","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.12.003_bib6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0735-1097(02)02767-5","article-title":"Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trial","volume":"41","author":"Tolleson","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.12.003_bib7","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/01.CIR.0000139868.53594.24","article-title":"Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention","volume":"110","author":"Brener","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.12.003_bib8","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization","volume":"336","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2015.12.003_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)85010-1","article-title":"Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb\/IIIa blockade","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2015.12.003_bib10","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/S0140-6736(00)03400-0","article-title":"Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial","volume":"356","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2015.12.003_bib11","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1161\/01.CIR.103.24.3019","volume":"103","author":"Smith","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.12.003_bib12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/01.CIR.93.4.667","article-title":"Relation between activated clotting time during angioplasty and abrupt closure","volume":"93","author":"Narins","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.12.003_bib13","doi-asserted-by":"crossref","first-page":"728S","DOI":"10.1378\/chest.114.5_Supplement.728S","article-title":"3rd. Antithrombotic therapy in patients undergoing coronary angioplasty","volume":"114","author":"Popma","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2015.12.003_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ccd.1810180403","article-title":"Adequate heparinization during PTCA: assessment using activated clotting times","volume":"18","author":"Ogilby","year":"1989","journal-title":"Cathet Cardiovasc Diagn"},{"key":"10.1016\/j.amjcard.2015.12.003_bib15","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0002-9149(03)00117-6","article-title":"Association of an activated clotting time \u2264250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy)","volume":"91","author":"Pinto","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2015.12.003_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9149(02)02988-0","article-title":"Efficacy and safety of minimal dose (\u22641,000 units) unfractionated heparin with abciximab in percutaneous coronary intervention","volume":"91","author":"Denardo","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2015.12.003_bib17","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2459\/01.JCM.0000253830.64753.0b","article-title":"Safety and efficacy of low-dose unfractionated heparin during percutaneous coronary revascularisation and the relationship between activated clotting time and haemorrhagic or ischaemic complications: our results","volume":"7","author":"Capuano","year":"2006","journal-title":"J\u00a0Cardiovasc Med"},{"key":"10.1016\/j.amjcard.2015.12.003_bib18","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.amjcard.2009.06.036","article-title":"Impact of final activated clotting time after transradial coronary stenting with maximal antiplatelet therapy","volume":"104","author":"Bertrand","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2015.12.003_bib19","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.jacc.2011.07.021","article-title":"Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial","volume":"58","author":"Suh","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.12.003_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCINTERVENTIONS.114.002044","article-title":"Activated clotting time and outcomes during percutaneous coronary intervention for non-ST-segment-elevation myocardial infarction: insights from the FUTURA\/OASIS-8 Trial","volume":"8","author":"Ducrocq","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2015.12.003_bib21","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2015.12.003_bib22","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2015.12.003_bib23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(14)61216-2","article-title":"Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials","volume":"384","author":"Cavender","year":"2014","journal-title":"Lancet"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915023413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915023413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:23:20Z","timestamp":1537143800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914915023413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0002914915023413"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.12.003","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relation of Activated Clotting Times During Percutaneous Coronary Intervention to Outcomes","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}